CYP1A2 and bladder transitional cell carcinoma: The meticulous odds ratio (OR) analysis underscores the significance of the rs762551 (CYP1A2-163 C/A) and rs2069514 (CYP1A2-3860G/A) variants, positioning them as potential genetic markers for heightened BLCA risk.